(HealthDay News) — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those ...
Daily Express US on MSN4h
Weight loss drugs linked to blindness in new studyA study found that a popular diabetes drug also used for weight loss is linked in rare cases to vision problems as doctors ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback